Ionis Pharmaceuticals | IONS - Equity Capital And Reserves


Ionis Pharmaceuticals reported $439.74M in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
Agios Pharmaceuticals USD 1.03B 83.09M Jun/2026
Alnylam Pharmaceuticals USD 1.35B 278.74M Jun/2026
Arrowhead Research USD 465.53M 148.45M Jun/2026
Astellas Pharma JPY 1.94T 113.64B Jun/2026
BioCryst Pharmaceuticals USD -454.29M 99.55M Jun/2026
BioMarin Pharmaceutical USD 6.21B 125.11M Mar/2026
Celltrion KRW 434.82B 1.14B Mar/2026
Cspc Pharmaceutical CNY 33.18B 71.46M Dec/2025
Deva Holding AS TRY 5.79B 604.07M Sep/2023
Divis Laboratories Ltd INR 167.61B 13.48B Mar/2026
Exelixis USD 1.94B 225.57M Mar/2026
Halozyme Therapeutics USD 219.64M 170.82M Mar/2026
Ionis Pharmaceuticals USD 439.74M 51.68M Jun/2026
Kangmei Pharma CNY 7.31B 84.82M Mar/2026
Knight Therapeutics CAD 767.27M 480K Dec/2025
Laboratorios Farma EUR 539.39M 22.74M Dec/2023
Malin Corporation EUR 193.2M 75M Dec/2024
Medical Developments International AUD 54.77M 335K Dec/2025
Moderna USD 6.76B 647M Jun/2026
Nektar Therapeutics USD 576.22M 486.38M Mar/2026
Neuren Pharmaceuticals AUD 338.45M 15.18M Dec/2025
Neurocrine Biosciences USD 3.69B 286.2M Jun/2026
Novartis USD 41.95B 3.02B Jun/2026
Omeros USD -228.68M 15.13M Jun/2025
OPKO Health USD 1.2B 63.35M Mar/2026
Organigram Holdings CAD 371.81M 2.36M Mar/2026
Ovoca Bio EUR 780K 485K Dec/2025
Pfizer USD 85.19B 4.91B Jun/2026
Pharma Mar EUR 250.77M 1.1M Jun/2026
PTC Therapeutics USD -165.36M 15.1M Jun/2026
Qiagen NV USD 3.33B 446.45M Mar/2026
Regeneron Pharmaceuticals USD 31.71B 287.8M Jun/2026
Roche Holding CHF 32.69B 1.11B Jun/2026
Sarepta Therapeutics USD 1.53B 22.7M Jun/2026
Sartorius EUR 2.82B 96.3M Jun/2026
Sino Biopharmaceutical CNY 34B 1.48B Jun/2025
Tilray USD 1.58B 39.08M Sep/2025
Ultragenyx Pharmaceutical USD -291M 55M Jun/2026
Vertex Pharmaceuticals USD 20.25B 886M Jun/2026
Zealand Pharma A/S 14.47B 361.61M Mar/2026
Zz Pientze Pharmaceu CNY 15.21B 740.32M Mar/2026